AFT Pharmaceuticals Ltd.'s total assets for Q2 2026 were $171.62M, an increase of 1.06% from the previous quarter. NZ:AFT total liabilities were $73.64M for the fiscal quarter, a 1.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.